Dr. Khan is a graduate of the University of Toronto, Faculty of Medicine (1992). After completion of his family medicine training in 1994, he joined a palliative home care team at his local hospital. This is how his focus on cancer patients began. In 2006, Dr. Khan co-founded Medicor Cancer Centres, the first integrated private cancer clinic of its kind in Canada. Since 2007, Dr. Khan gained international recognition for his work with the non-chemo drug dichloroacetate (DCA). He is privileged to be the first doctor in the world to prescribe off-label DCA to treat cancer with positive results. As a result, he now has the most DCA experience of any physician in the world with over 2000 cancer patients.
Dr. Khan also uses low dose naltrexone (LDN) in his cancer practice. He has published the world’s first paper showing complete remission of adenoid cystic carcinoma using just LDN and vitamin D: “Long-term remission of adenoid cystic tongue carcinoma with low dose naltrexone and vitamin D3 – a case report," Khan A, Oral Health Dent Manag. 2014 Sep;13(3):721-4. Dr. Khan regularly publishes ground-breaking cancer papers in peer-reviewed medical journals.